Skip to main content
Fig. 6 | BMC Immunology

Fig. 6

From: Comprehensive analysis of immunoglobulin and clinical variables identifies functional linkages and diagnostic indicators associated with Behcet’s disease patients receiving immunomodulatory treatment

Fig. 6

Significant ratio changes between BD and HC and disease controls in the discovery and validation sets. a. Boxplot of the levels of the four ratios in HCs and BD patients with and without treatments in the discovery set. b. Boxplot of the levels of the four ratios in HCs, BD patients with and without treatments, and patients with ANCA-associated vasculitis and Takayasu arteritis in the validation set. HC: healthy controls; BD-N: BD patients not receiving corticosteroid or immunosuppressant treatment; TA: Takayasu arteritis; AAV: ANCA-associated vasculitis

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us